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Introduction
The superfamily of mammalian cytosolic sulfotransferases (SULTs) contribute to the metabolism of a wide range of xenobiotics that include drugs, carcinogens, and environmental contaminants as well as endogenous steroid hormones, bile acids, catecholamines and iodothyronines (Falany, 1997; Glatt et al., 2000; Duffel et al., 2001; Coughtrie, 2002; Duffel, 2010) . Although the various isoforms often have distinct, but overlapping, specificities for substrates and inhibitors, it is becoming increasingly apparent that other factors such as the redox environment of these enzymes can have additional effects on catalysis. For example, several family 1 SULTs have been shown to be sensitive to oxidants that cause formation of disulfide bonds (Marshall et al., 1997; Marshall et al., 2000; Duffel et al., 2001; Maiti et al., 2005; Maiti et al., 2007; Liu et al., 2011; Dammanahalli and Duffel, 2012) . Moreover, it is clear that, in addition to the rates of catalysis, substrate specificity may be altered by disulfide bond formation in family 1 SULTs (Marshall et al., 2000; Duffel et al., 2001; Liu et al., 2011) .
While the effects of thiol oxidants on the catalytic function of family 1 SULTs have been studied, the potential for alteration in the catalysis of family 2 enzymes has not received an appropriate amount of attention. We have hypothesized that a family 2 SULT, such as the human hydroxysteroid sulfotransferase hSULT2A1, might also be subject to alteration of its catalytic function by thiol-oxidants. The hSULT2A1 isoform is a major human SULT that catalyzes the sulfation of endogenous alcohol-containing steroids such as dehydroepiandrosterone (DHEA), pregnenolone, androsterone, bile acids, and others. Moreover, this enzyme is also of interest due to its roles in bioactivation of carcinogens that contain, or are metabolized to, benzylic or allylic alcohols (Watabe et al., 1982; Surh and Miller, 1994; Glatt et al., 1997) . DMD #50534 5 An examination of the crystal structure of hSULT2A1 (e.g., PDB structure 1J99 )
indicates that there are no cysteine residues within the sulfuryl acceptor (e.g., DHEA) binding site of the protein. However, it should be noted that this is also the case in rSULT1A1, where there is pronounced regulation of catalytic rate and specificity through conformational alterations in the binding site for PAPS and PAP .
When the structure of hSULT2A1 is examined with respect to the PAPS/PAP binding site (e.g., PDB structure 1EFH), it is clear that two cysteine residues Cys55 and Cys199 are near this nucleotide binding site in the protein. This location of cysteines in relation to the PAPS/PAP binding site led us to investigate the effect of disulfide bond formation on the catalysis of hSULT2A1.
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Materials and Methods
Chemicals
Dehydroepiandrosterone (DHEA), 1,1 '-azobis(N,N-dimethylformamide) (Diamide), L-glutathione (GSH), L-glutathione disulfide (disodium salt) (GSSG), 5,5'-Dithiobis(2-nitrobenzoic acid) (DTNB), adenosine 3',5'-diphosphate sodium salt (PAP), methylene blue, 2-mercaptoethanol and 4-vinylpyridine were purchased from SigmaAldrich (St. Louis, MO). 8-Anilinonaphthalene-1-sulfonic acid ammonium salt (ANS) was purchased from Fluka (Steinheim, Germany). Adenosine 3'-phosphate, 5'-phosphosulfate (PAPS) was purchased from Sigma-Aldrich, and was further purified by anion-exchange chromatography (Sekura, 1981) to reach at least 98 % purity (as determined by HPLC analysis). Modified trypsin and Glu-C (both sequencing grade) were purchased from Promega (Madison, WI). Precast 12% SDS-PAGE gels were purchased from Bio-Rad Labs (Hercules, CA). Radiolabeled 
Expression and purification of recombinant hSULT2A1
Recombinant human SULT2A1 was expressed in Escherichia coli BL21 (DE3) cells (Sheng and Duffel, 2003) , the cells were lysed and extracted, and the enzyme was purified as previously described (Gulcan et al., 2008) . After each step in the purification procedure, hSULT2A1 was initially monitored for sulfation activity with the methylene blue assay using dehydroepiandrosterone (DHEA) as substrate (Nose and Lipmann, 1958; Sheng et al., 2001) . Protein content was determined by the modified Lowry procedure with bovine serum albumin as standard (Bensadoun and Weinstein, 1976) .
Following purification, SDS-PAGE with Coomassie brilliant blue staining yielded a single DMD #50534 8 DHEA. This reaction mixture was incubated in a 37 °C water bath for 2 minutes prior to addition of 30 ng (in a 2 µL volume) of the oxidant-treated hSULT2A1 (final concentration of the enzyme was 2.2 nM based on M r of the dimeric protein). This reaction was carried out at 37 °C for either 3 or 4 minutes (incubation time adjusted to maintain initial velocity conditions). The reaction was terminated by addition of 0.8 mL of 50 mM potassium hydroxide, and analysis of the DHEA-sulfate formed was carried out as previously described (Gulcan and Duffel, 2011) . Relative IC 50 values were obtained by fitting data to a sigmoidal dose-response curve using SigmaPlot 11.0 (Systat Software, Chicago, IL). The mean ± standard deviation of three replicates was determined for each assay.
Ligand-binding studies
ANS was utilized as a fluorescent probe for determination of the binding of ligands (e.g., DHEA and PAP) to both the unmodified and the oxidized hSULT2A1 using the previously described procedure for the study of rSULT1A1 (Marshall et al., 1997; Liu et al., 2011 ) with a modification wherein concentrations of ANS were selected by determining conditions of saturation under the conditions that were used in the assay (Supplemental Figure S1 ). Binding of ligands to the enzyme was determined at 37 °C in Conformational alterations in hSULT2A1 upon interaction with ligands were also determined by changes in the intrinsic fluorescence of tryptophan residues as described previously (Beechem and Brand, 1985; Gulcan and Duffel, 2011) . Both kinetic and crystallographic studies have shown that PAP and PAPS bind at the same binding site in each SULT (Yoshinari et al., 2001; Chapman et al., 2004; Wang and James, 2006) , and we determined binding at this site by titration with PAP. These studies were conducted in 0.25 M potassium phosphate, pH 7.4, with an excitation wavelength of 290 nm and an emission wavelength of 347 nm (entrance and the exit slits were set at 5 nm and 7 nm, respectively). )/2.303A) (Birdsall et al., 1983) .
Structural characterization of oxidatively modified hSULT2A1
The structural modification of hSULT2A1 by thiol oxidants was detected and exclusion column was used to remove the DTT that remained from the purification of hSULT2A1, and this column was eluted with 50 mM Tris-HCl buffer, pH 8.0. The resulting enzyme was concentrated to approximately 2 µg/µL, and the removal of DTT was verified using the assay described above. Aliquots of hSULT2A1, each containing 15 µg of enzyme in a 25 µL volume, were incubated for 1 hour at 25 °C with various thiol oxidants followed by addition of 4-vinylpyridine (45 mM final concentration of 4-vinylpyridine). Following incubation for another 1 hour, proteolytic digestion was carried out by adding 0.6 µg of sequencing grade trypsin in 50 mM Tris-HCl buffer (pH 8.0) and acetonitrile (final 10% v/v) in a total volume of 0.1 mL, and incubating at 37 ˚C for 16 h.
In those cases where a secondary digestion was performed, 1µg of sequencing grade Glu-C was added immediately after the 16 h tryptic digestion, and the mixture was 
Computational modeling studies on hSULT2A1
Sybyl X (Tripos; St. Louis, MO) was utilized to suggest potential conformational changes in hSULT2A1 after oxidative modifications. The previously reported x-ray structure of hSULT2A1 with the cofactor PAP bound (Pedersen et al., 2000) was DMD #50534 1 2 obtained from the Protein Data Bank (PDB file: 1EFH). PAP was extracted from the original structure, and the conformation of the resulting structure was optimized using the Prepare Structure application in Sybyl X. The optimization included fixing the terminal ends by adding charges at the terminus, adding back missing hydrogens on the side chain of the amino acid residues, as well as fixing the side chain steric interactions in the structure followed by energy minimization. The Powell method was used for the initial optimization with a termination gradient of 0.5 kcal/(mol*A). The force field was set at the Tripos default value with Gasteiger-Hückel charges using an 8.00 Å nonbonding interaction cutoff. The maximum number of iterations was set at 1500 for the calculation.
A disulfide bond was constructed between Cys55 and Cys199, and the resulting structural model was minimized as noted above. For modeling of the effect of mixed disulfide formation with glutathione (GSH) on the conformation of the protein, the structure of GSH was constructed with the build protein apparatus in the biopolymer suite, and it was merged into the optimized structure of hSULT2A1 with addition of a covalent bond to link the cysteine in GSH to the Cys55 or Cys199 of the protein via disulfide bonds. Bond angles were adjusted to avoid any side chain bumps, and a regional minimization was performed using a terminal gradient of 0.1 kcal/(mol*A) and the same force field as previously described. Overall stage energy minimization was conducted with same setting as for the original structure with the exception to allow Calpha changes. The energy-minimized modified hSULT2A1 was saved as a PDB file and aligned with the optimized unmodified structure of hSULT2A1 that had been developed based on PDB File:1EFH. The structural model with the disulfide bond between Cys55 and Cys199 was subjected to analysis using Verify_3D and Procheck (NIH Structural Analysis and Verification Server -SAVeS). While, as expected, a localized higher energy was noted for the disulfide bond, the overall protein structure of the model was acceptable when related to similar analysis of the crystal structure of the reduced protein (original file 1EFH). The protein backbones of the two models were 
Results
Regulation of the catalytic activity in hSULT2A1 by disulfide bond formation
Previous reports have indicated that oxidants capable of forming disulfide bonds with cysteines (e.g., diamide, DTNB, and GSSG) can regulate the catalytic activity of rSULT1A1, the major family 1 SULT in rat liver (Marshall et al., 1997; Duffel et al., 2001) . Either formation of a Cys66-glutathione disulfide or an intramolecular disulfide bond, Cys66-Cys232, can alter the protein conformation near the PAPS/PAP binding site in rSULT1A1 and lead to catalytic alterations (Marshall et al., 1997; Duffel et al., 2001 ).
We utilized diamide and DTNB in preliminary experiments to examine both the ability of hSULT2A1 to form intramolecular disulfides and the effect of this alteration on catalytic function. The results indicated a decrease in the catalytic activity of hSULT2A1 following incubation with either diamide or DTNB for periods up to one hour, but no significant change was observed after additional exposure to these oxidants ( Figure 1 ).
Thus, a one hour incubation with oxidants was applied as a pretreatment throughout subsequent studies.
In addition to diamide and DTNB, GSSG was used as a model oxidant for hSULT2A1, and this was compared with catalysis in the presence of GSH at varied concentrations of DHEA as substrate. As shown in Figure 2 , the effects of 1mM GSSG or 1 mM GSH on catalysis were examined by co-incubation with hSULT2A1 for one hour at 25 o C. Following this incubation, the enzyme was diluted 100-fold into a standard assay for determination of hSULT2A1 activity at 37 
Reversibility of oxidative modifications of hSULT2A1
Since the reversibility of oxidative modification of family 1 SULTs has been previously demonstrated (Maiti et al., 2007) , we sought to determine the reversibility of disulfide bond formation in hSULT2A1. Following a 1 hr treatment of hSULT2A1 with 0.5 mM diamide or 0.5 mM DTNB, 5mM DTT was added, and the mixture was further incubated in 25 °C for another 1 hr prior to conducting an assay for catalytic activity with DHEA as substrate. As seen in Figure 3A , recovery of catalytic activity was observed for diamide-pretreated hSULT2A1 after restoring the reducing environment. Likewise, the addition of DTT into the DTNB-pretreated hSULT2A1, resulted in recovery of approximately 80 % of the value seen with untreated hSULT2A1 ( Figure 3B ). When using GSH-treated hSULT2A1 as control, the GSSG-treated enzyme showed a statistically significant decrease in the rate of DHEA-sulfation, and this effect was reversed by addition of DTT ( Figure 3C ).
Alteration in kinetic characteristics of the hSULT2A1-catalyzed sulfation of DHEA
The kinetic characteristics of oxidized as well as untreated hSULT2A1 were examined for the sulfation of DHEA at substrate concentrations ranging from 0.25 μ M-10 μ M. As noted previously (Falany et al., 1989; Gulcan and Duffel, 2011) , hSULT2A1 that had not been subjected to treatment with oxidants displayed substrate inhibition kinetics (Figure 4 ). Based on this characteristic kinetic profile, we applied an equation for substrate inhibition kinetics (shown below) to calculate the kinetic constants for untreated as well as oxidant-treated hSULT2A1.
As seen in Table 1 , values for K m , V max , and K i with the untreated hSULT2A1 were 178 ±35 nmol/min/mg, 1.3 ± 0.4 µM, 6.2 ± 2.4 µM, respectively. After treatment with GSSG, a slight increase in V max value was observed compared to the GSH-pretreated enzyme, however, K i and K m values were not significantly changed (Table 1) . A similar effect on the V max value was observed for 0.5 mM DTNB-treated hSULT2A1 (268 ± 14 nmol/min/mg) (Table1 and Figure 4) , whereas a decrease in V max value was observed for 0.5 mM diamide-pretreated hSULT2A1 at 145 ± 5 nmol/min/mg (Table 1 and Figure   4 ). As shown in Table 1 , there were no significant differences in the K m values for DHEA observed in all the oxidative pretreatment cases when compared to the untreated enzyme. Although there was no significant change seen in the calculated K i value for the GSSG-pretreated enzyme compared to untreated hSULT2A1, both diamide-and DTNB-treated hSULT2A1 exhibited a loss of substrate inhibition (Table 1 , Figure 4 , and Supplemental Figure S2 ).
Binding of substrate and products following disulfide bond formation in hSULT2A1
The loss of substrate inhibition upon oxidation of hSULT2A1 indicated the potential for changes in the binding of DHEA, PAPS, and/or PAP to the enzyme. The binding of these substrates and products to hSULT2A1 is essential in the formation of a dead-end complex that causes substrate inhibition (Zhang et al., 1998; Gulcan and Duffel, 2011) . Binding of DHEA to untreated and oxidant-treated hSULT2A1 was showed a relatively small change in the K d1 value in the absence of DHEA (Table 3) .
Pretreatment of hSULT2A1 with GSSG in the absence of DHEA only caused a relatively small change in the dissociation constant at the second binding site for PAPS/PAP, and no significant changes in the binding of PAP were observed following treatment with either diamide or DTNB (Table 3 ).
The binding of PAP to the oxidant-treated hSULT2A1 was also determined in the presence of either 0.5 µM or 50 µM DHEA in the final assay mixture (Table 3 ). In the case of the untreated enzyme, K d1 and K d2 values were not significantly different from those obtained without DHEA present (Table 3) . Pretreatment of hSULT2A1 with 1 mM GSH resulted in a small increase in the value of K d1 for PAP when 0.5 µM DHEA was present and an increase in K d2 when 50 µM DHEA was present (Table 3) . Pretreatment with 1 mM GSSG increased the K d2 for PAP-binding in the presence of 50 µM DHEA (Table 3) , however, this was not the case in the presence of 0.5 µM DHEA (Table 3) .
Treatment of hSULT2A1 with DTNB had no effect on the binding of PAP in the presence of 50 µM DHEA (Table 3 ), but significant increases in both K d1 and K d2 occurred in the presence of 0.5 µM DHEA (Table 3) . Pretreatment with diamide yielded no significant effect on the binding of PAP in the presence of either 0.5 µM or 50 μM DHEA (Table 3) .
This article has not been copyedited and formatted. The final version may differ from this version. 
Oxidative modifications of hSULT2A1 identified by LC-MS
Structural modifications of hSULT2A1 following pretreatment with oxidants were analyzed by proteolytic digestion followed by LC-MS using a quadrupole ion trap mass spectrometer. After treatment with each oxidant, 4-vinylpyridine (45 mM) was added to the hSULT2A1 to alkylate remaining free cysteine thiols and, thereby, preclude any disulfide exchange during the later digestion steps. Following tryptic digestion, peptides with pretreatments were analyzed by LC-ESI-MS. Ions formed from peptides in the ESI process can be multiply-charged, which allows us to detect peptides that have molecule weights higher than 2000 within the mass range of the mass spectrometer. The presence of those tryptic peptides that bear masses higher than 2000 could be identified by searching for their corresponding doubly-or triply-charged ions in the mass spectral data. In control experiments, hSULT2A1 that had not been treated with oxidants was subjected to reaction with 45 mM vinylpyridine. Three 4-vinylpyridineadducted cysteines including Cys55, Cys199 and Cys154 were found in tryptic peptides (data not shown). Reaction of hSULT2A1 with GSSG resulted in two additional chromatographic peaks, and these corresponded to glutathione mixed disulfides at Cys199 and Cys55, respectively (Table 4) . Proteolytic cleavage with Glu-C following the tryptic digestion of the enzyme confirmed the findings from the single reaction of the modified hSULT2A1 with trypsin. Following the digestion with both trypsin and Glu-C, an additional Cys154-glutathione mixed disulfide adduct was identified by LC-MS (Table 4) .
After reaction of hSULT2A1 with diamide, tryptic digestion LC-MS analysis showed a loss of all three 4-vinylpyridine-modified cysteines and the formation of a disulfide bond between Cys55 and Cys199 was observed, although (M+4H) 4+ ion was in low abundance (Table 4) . A secondary digestion of the tryptic peptide with Glu-C confirmed the findings that diamide-pretreatment resulted in a disulfide bond between Cys55 and Cys199 ( Table 4) . As also seen in Table 4 , LC-MS analysis of hSULT2A1 following reaction with DTNB, and subsequent proteolytic digestion, showed that all three cysteines in hSULT2A1 were modified by formation of a thionitrobenzoic acid (TNB) adduct.
Conformational alterations in hSULT2A1 following oxidative modification
Since formation of disulfide bonds in hSULT2A1 would likely lead to conformational changes in the protein structure, we examined changes in the intrinsic fluorescence of the enzyme as a sensitive indicator of these alterations in structure Following reaction with 1 mM GSSG, there was only a small time-dependent decrease in the intrinsic fluorescence of hSULT2A1, and this was reversed by addition of 2-mercaptoethanol (Supplemental Figure S4) . A control experiment utilizing 1mM GSH yielded no significant change in the intrinsic fluorescence of hSULT2A1 (data not shown). It was not possible to utilize this method of analysis for treatment of the enzyme with DTNB due to its high absorption at a wavelength overlapping with the excitation wavelength of tryptophan.
Modeling of conformational alterations in hSULT2A1 following disulfide bond formation
Energy-minimized structural models of an intramolecular disulfide bond between Cys55 and Cys199 revealed an overall alteration in the C-backbone structure of The modeled structures of hSULT2A1 were also compared both before and after formation of a mixed disulfide with glutathione at Cys55 and Cys199, and small changes in the C-alpha backbone near the positions of modification were observed (Supplemental Figure S5 ). These conformational changes included the binding region for PAPS and PAP in the enzyme. It is also noteworthy that the glutathione tri-peptide side chain that is bound to Cys55 in the energy-minimized model is pointing out toward the exterior of the globular structure of hSULT2A1, and this may limit the conformational change in the backbone structure.
This article has not been copyedited and formatted. The final version may differ from this version. Mieyal et al., 2008; Dalle-Donne et al., 2009; Jones and Go, 2010) . Oxidative regulation of the catalytic activity of cytosolic sulfotransferases has been demonstrated in family 1 SULTs including members of both SULT1A as well as SULT1E subfamilies (Marshall et al., 1997; Maiti et al., 2005; Maiti et al., 2007) . Our results from the present study indicate that the catalytic activity of hSULT2A1, an important member of the SULT2 family in humans, can also be modulated through oxidation at cysteine residues.
Previous studies on the rat hepatic rSULT1A1 showed that the oxidation of Cys66 and Cys232 could reversibly alter the catalytic activity of the enzyme through conformational changes affecting the PAPS/PAP binding site (Marshall et al., 1997; Marshall et al., 2000; Duffel et al., 2001 ). This change in conformation and activity occurred as a result of formation of either a Cys66-glutathione disulfide or an intramolecular disulfide bond between Cys66 and Cys232 (Marshall et al., 1997; Duffel et al., 2001) . By virtue of their proximity to the PAPS/PAP binding site, Cys55 and Cys199 represent the analogous cysteines in hSULT2A1. Our finding that reaction of hSULT2A1 with GSSG, DTNB, or diamide reversibly decreased the catalytic activity of hSULT2A1 indicates that this SULT is also subject to catalytic modification by formation of disulfide bonds.
In the case of GSSG, we observed that the effects on hSULT2A1-catalyzed sulfation of DHEA only occur at low concentrations of DHEA (i.e., less than or equal to 1 μM in the assay). This suggests that at lower, more physiologically relevant, concentrations of DHEA, the effect of disulfide bond formation may be more significant than under conditions of higher substrate concentration. Indeed, our results at higher concentrations of DHEA are consistent with a previous report where there was no effect of GSSG treatment on hSULT2A1 (Chen et al., 2006; Maiti et al., 2007) . This dependence on substrate concentration is most likely linked to the substrate inhibition of hSULT2A1 by DHEA at concentrations higher than 1.0 to 1.5 μ M.
In our results, a mixed disulfide with glutathione was found at both Cys55 and consistent with the elimination of a substrate inhibition complex as evident from the increased K i in the kinetic assays. These conformational changes, however, had no effect on DHEA binding. It is also evident that differences in the effects of DTNB on substrate binding and catalysis when compared with the other oxidants may relate to the very different structures of the cysteine disulfides/adducts formed.
LC-MS structural analysis showed the formation of a disulfide bond between Cys55 and Cys199 in hSULT2A1 following reaction of the protein with diamide. When the LC-MS results were combined with our fluorescence studies, it was clear that the disulfide bond between Cys55 and Cys199 in hSULT2A1 resulting from diamidetreatment caused an alteration in the conformation of the protein. The overall result of this modification in the structure of hSULT2A1 was a loss of substrate inhibition. When this result was combined with the effects of treatment of the enzyme with GSSG, where there was also a decrease in the K d2 for DHEA binding, we considered a previously proposed mechanism for substrate inhibition in hSULT1A1 where a second substrate binds at the same active site (Gamage et al., 2006) . However, in the case of reaction of hSULT2A1 with DTNB, there are no significant changes in the K d2 for DHEA binding.
This indicates that there are either multiple mechanisms for substrate inhibition in hSULT2A1 that depend upon the structure of the modified cysteine residue(s) or that the effects are primarily due to increases in the K d values for binding of PAPS/PAP.
Such changes in substrate inhibition and K d values highlight the complexity of protein conformational changes occurring in hSULT2A1. The first studies on the crystal structure of hSULT2A1 (Pedersen et al., 2000) suggested the possibility of conformational changes related to the dimeric structure could regulate enzyme activity.
Indeed, an important dimer interface sequence in the active hSULT2A1 was identified by site-directed mutagenesis and kinetic studies .
Interestingly, there is a significant discrepancy between this dimeric interface and the interface formed between monomers in the crystals of hSULT2A1 (Petrotchenko et al., This article has not been copyedited and formatted. The final version may differ from this version. rSULT1A1 have shown that oxidative effects on the catalytic function of the purified enzyme (Marshall et al., 1997; Marshall et al., 2000; Duffel et al., 2001 ) are consistent with effects seen in precision cut tissue slices (Dammanahalli and Duffel, 2012) .
Similarities in the mechanisms of catalytic alterations seen with the two SULTs suggest that regulation by disulfide bond formation may occur within intact cells, however, the response of hSULT2A1 to disulfide bond formation within intact cells remains to be The hSULT2A1 was pretreated, either with or without oxidants, at 25 ˚C for 1 hour followed by a 100-fold dilution into a standard assay to determine the rate of sulfation using 200 µM PAPS and concentrations of DHEA ranging from 0.25 µM to 10 µM. An entry of N/A in the table indicates a K i value that was greater than 10 6 µM, and thus no significant substrate inhibition occurred.
This article has not been copyedited and formatted. The final version may differ from this version. *indicates a peptide resulting from the double-digestion procedure using both trypsin and Glu-C.
